ACTR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.175000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.900000E-02
Normal-vs-Stage2
1.522770E-01
Normal-vs-Stage3
4.963700E-02
Normal-vs-Stage4
4.614400E-01
Stage1-vs-Stage2
2.281200E-01
Stage1-vs-Stage3
8.307800E-01
Stage1-vs-Stage4
1.713420E-01
Stage2-vs-Stage3
2.189800E-01
Stage2-vs-Stage4
4.823600E-01
Stage3-vs-Stage4
1.837980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.071180E-01
Normal-vs-AfricanAmerican
3.403000E-01
Normal-vs-Asian
1.095950E-01
Caucasian-vs-AfricanAmerican
5.786800E-01
Caucasian-vs-Asian
7.125400E-01
AfricanAmerican-vs-Asian
5.240200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.359040E-01
Normal-vs-Female
1.064000E-01
Male-vs-Female
7.504800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.719420E-01
Normal-vs-Age(41-60Yrs)
3.002400E-01
Normal-vs-Age(61-80Yrs)
7.767700E-02
Normal-vs-Age(81-100Yrs)
1.044370E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.345400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.688400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.043400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.502500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.324100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.603000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.063600E-02
Normal-vs-Daily Drinker
3.601700E-02
Normal-vs-Weekly Drinker
1.354810E-01
Normal-vs-Occasional Drinker
4.463600E-01
Normal-vs-Social Drinker
1.130600E-01
Non Drinker-vs-Daily Drinker
3.870400E-01
Non Drinker-vs-Weekly Drinker
3.421600E-01
Non Drinker-vs-Occasional Drinker
1.955560E-01
Non Drinker-vs-Social Drinker
7.387800E-01
Daily Drinker-vs-Weekly Drinker
1.342780E-01
Daily Drinker-vs-Occasional Drinker
6.648500E-02
Daily Drinker-vs-Social Drinker
3.364600E-01
Weekly Drinker-vs-Occasional Drinker
6.290800E-01
Weekly Drinker-vs-Social Drinker
6.209600E-01
Occasional Drinker-vs-Social Drinker
3.770400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.388400E-01
Normal-vs-Grade 2
8.073800E-01
Normal-vs-Grade 3
8.053800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.325600E-02
Grade 1-vs-Grade 3
5.142200E-02
Grade 1-vs-Grade 4
9.388400E-01
Grade 2-vs-Grade 3
9.617600E-01
Grade 2-vs-Grade 4
8.073800E-01
Grade 3-vs-Grade 4
8.053800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.062800E-01
Normal-vs-NonDiabetic
9.925700E-02
Diabetic-vs-NonDiabetic
8.519800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.739600E-03
Normal-vs-NoPancreatitis
1.229000E-01
Pancreatitis-vs-NoPancreatitis
1.550030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.062400E-02
Normal-vs-N1
1.542840E-01
N0-vs-N1
1.266000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.910200E-01
Normal-vs-TP53-NonMutant
2.552200E-02
TP53-Mutant-vs-TP53-NonMutant
9.83719999999577E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
